• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Peregrine Pharmaceuticals, Inc. (PPHM)

    -NasdaqCM
    1.42 Down 0.04(2.74%) 4:00PM EST
    |After Hours : 1.42 0.00 (0.00%) 4:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingApr 30, 2014Apr 30, 2013Apr 30, 2012
    Total Revenue 22,401   21,683   15,233  
    Cost of Revenue13,110  12,595  10,153  
    Gross Profit 9,291   9,088   5,080  
    Operating Expenses
    Research Development27,723  24,306  35,688  
    Selling General and Administrative17,274  13,134  11,462  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (35,706) (28,352) (42,070)
    Income from Continuing Operations
    Total Other Income/Expenses Net349  (1,374)41  
    Earnings Before Interest And Taxes(35,357)(28,030)(42,029)
    Interest Expense5  54  90  
    Income Before Tax(35,362)(28,084)(42,119)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(35,362)(29,780)(42,119)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (35,362) (29,780) (42,119)
    Preferred Stock And Other Adjustments(401) -   -  
    Net Income Applicable To Common Shares (35,763) (29,780) (42,119)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.